Yeruusaalem, 10 December, 2025 (TPS-IL) — Shirkadda Israa’iil ee EyeYon Medical ayaa heshay ogolaansho FDA ah si ay u bilowdo daraasad caafimaad oo Maraykan ah oo ku saabsan EndoArt, oo ah lakabka indhaha ee macmalka ah oo loogu talagalay in lagu daaweeyo bararka joogtada ah ee indhaha iyo in lagu caawiyo soo celinta aragti cad oo indhaha bukaanka ah. Shirkadda oo fadhigeedu yahay Nes Ziona ayaa sheegtay in ogolaanshaha daraasadda ee qalabka baaritaanka uu u oggolaan doono ugu yaraan 10 dhakhtar oo sare oo indhaha ah oo Maraykan ah inay tijaabiyaan qalabka, kaas oo horay loo siiyay magaca Qalabka Burburka.
Madaxa daraasadda Prof. Francis Mah ayaa ku tilmaamay EndoArt inuu yahay hab cusub oo lagu daaweeyo cudurka. Madaxa Fulinta Nahum Ferera ayaa sheegay in ogolaanshahaasi uu yahay tallaabo weyn, isagoo xusay in qalabka la isticmaalayo si ballaaran Yurub iyo in ka badan 800 oo qalliin oo adduunka ah.



